首页/数据集/Crude and adjusted odds ratio of BPAR associated with d-sp ELISPOT.

Crude and adjusted odds ratio of BPAR associated with d-sp ELISPOT.

Figshare2018-07-30 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Crude_and_adjusted_odds_ratio_of_BPAR_associated_with_d-sp_ELISPOT_/6878324 数据链接链接失效反馈

官方服务：

资源简介：

Crude and adjusted odds ratio of BPAR associated with d-sp ELISPOT.

应用场景：

创建时间：

2018-07-30

实体器官移植

移植排斥风险评估

Background Anti-human leukocyte antigen donor-specific antibodies (anti-HLA DSAs) are recognized as a major barrier to patients’ access to organ transplantation and the major cause of graft failure. T

NIAID Data Ecosystem40

Eligibility criteria.

移植排斥风险评估

微血管功能

Background Acute allograft rejection (AAR) is an important cause of morbi mortality in heart transplant (HT) patients, particularly during the first year. Endomyocardial biopsy (EMB) is the “gold stan

NIAID Data Ecosystem10

Table_1_Pre-transplant crossmatch-negative donor-specific anti-HLA antibody predicts acute antibody-mediated rejection but not long-term outcomes in kidney transplantation: an analysis of the Korean Organ Transplantation Registry.docx

肾脏移植免疫学

移植排斥风险评估

BackgroundPre-transplant donor-specific anti-human leukocyte antigen antibody (HLA-DSA) is a recognized risk factor for acute antibody-mediated rejection (ABMR) and allograft failure. However, the cli

NIAID Data Ecosystem00

Univariate analyses on the risk for developing de novo DSA.

器官移植免疫监测

移植排斥风险评估

Univariate analyses on the risk for developing de novo DSA.

Figshare2020-08-05 更新30

Reported High-Risk Amino Acid Residue Substitutions.

HLA免疫配型

移植排斥风险评估

Non-permissive residues between patient and donor HLA antigens or alleles reported to have deleterious outcomes in HCT [45], [46], [47], [48]. The observed residues from all known HLA-A alleles at eac

Figshare2015-12-02 更新10

Crude and adjusted odds ratio of BPAR associated with d-sp ELISPOT.

资源简介：

相关数据集